Cancer survivors can apply for life insurance in Australia. Learn what underwriters weigh when assessing a cancer history, how waiting periods work, and how to prepare an application.
Complete guide to life insurance in Australia covering types, costs, and how to apply
How 15 common medical conditions affect life insurance premiums, underwriting, and coverage in Australia
Complete guide to trauma insurance conditions covered in Australia
General Advice Only
Insure Me For Life is Authorised Representative Number 1244847 of Consilium Advice Australia Pty Ltd, Australian Financial Services Licence 246623.
Yes, cancer survivors can get life insurance in Australia. Each application is decided by an insurer's underwriting team based on the medical evidence. No broker can guarantee acceptance or a specific premium loading.
According to the Australian Institute of Health and Welfare (AIHW) Cancer Data in Australia report, cancer is a leading cause of disease burden in Australia. A substantial share of the working-age population has lived with a cancer diagnosis. Many of these survivors hold life insurance arranged after treatment ended.
Five factors shape a post-cancer application:
This guide explains how panel insurers typically assess cancer history. It covers waiting periods, the Stage 3.5 pre-assessment workflow, and the documentation underwriters need. It describes what insurers weigh, not what any insurer will decide, because appetite for the same cancer history differs materially across the panel. A pre-assessment through a broker is the only reliable way to gauge insurer appetite for your specific situation before submitting a formal application.
Words like "approved", "auto-approved", or "guaranteed acceptance" don't apply to advised retail life insurance for cancer survivors. Underwriters either accept at standard rates, accept with a loading, accept with an exclusion, postpone, or decline. We use those underwriting terms throughout.
Cancer-history applications usually go through manual underwriting. A senior underwriter reviews the medical evidence personally rather than an automated decision engine assessing it. This is normal for most cancer histories. It is not a sign of bad news.
Information the insurer will commonly request:
The pre-assessment step (also called "pre-underwriting" or "appetite check") is useful here. Your broker submits a de-identified medical summary to one or more panel insurers and receives an indicative response. For example, "likely standard terms after a further 12 months in remission". Or, "we would consider this with a loading and a cancer-related exclusion on trauma cover". A pre-assessment doesn't put a decline on your record. It lets you compare appetite across insurers before committing to a formal application.
1. Cancer Type
Insurers categorise cancers by risk profile:
2. Stage at Diagnosis
Cancer staging directly correlates with survival statistics, which insurers rely on. The underwriter takes the stage recorded at diagnosis, from Stage 0 (carcinoma in situ) through to Stage 4 (metastatic disease), together with the tumour grade and the extent of any regional or distant spread.
3. Time since treatment completion
The longer you've been cancer-free, the closer your risk approaches the general population, and the more evidence the underwriter has to work with. Insurers count elapsed time from the end of primary treatment or from confirmed remission.
4. Treatment modality
How your cancer was treated forms part of the file. Insurers look at whether treatment was surgical only or also involved radiotherapy, chemotherapy, immunotherapy or targeted therapy, and at whether any hormone or maintenance therapy is still ongoing.
5. Current health status
Overall health beyond cancer matters:
The five factors above do not combine into a lookup table. Waiting periods and terms vary significantly between insurers, by cancer type, stage, and individual medical history. We do not publish a fixed table of outcomes because:
The most reliable way to understand your specific outcome is pre-assessment. A broker anonymously submits your medical profile to the panel to gauge appetite before a formal application. This is usually free and avoids a decline on your record.
A premium loading is an additional charge on top of the standard premium to account for increased risk. Loadings are expressed as a percentage. For example, "+100% loading" means the premium is double the standard rate for someone of the same age, gender, and smoking status.
Whether a loading applies at all, and how large it is, is set by the underwriter on the medical evidence in the file. It is not derived from a published table, and it is not something the broker decides.
For detail on specific cancer types, including how each is commonly considered by underwriters, see our health condition pages:
For Australian cancer incidence, prevalence, and survival data, the AIHW Cancer Data in Australia report and the Cancer Council Australia statistics page are the primary public sources.
Insure Me For Life works with Australia's nine retail life insurance panel insurers: AIA, Zurich, TAL, OnePath, ClearView, NEOS, Encompass, Acenda, and Futura. Each publishes its own underwriting guide and has its own internal stance on cancer histories. The honest position:
We pre-assess across multiple panel insurers for any cancer-history application. That gives the strongest read on which insurer is most likely to offer terms, and on what shape (loading only, exclusion only, both, or neither). Pre-assessment is free, doesn't sit on your record, and is the most efficient way to surface realistic options before a formal application.
For industry-level claims acceptance data (not per-insurer per-condition), see the APRA Life Insurance Claims and Disputes Statistics. Industry-aggregated figures across advised channels show consistently high acceptance rates for finalised lump-sum claims. Acceptance rates on applications after cancer are not published by APRA. Those vary by insurer and case.
Insure Me For Life uses a "Stage 3.5" pre-assessment workflow for medically complex applications. After we've pulled together a quote and you've selected an insurer to proceed with, we run a structured medical pre-assessment before lodging the formal application. For cancer histories this typically involves:
The benefit is that a decline, if it's coming, surfaces here. It doesn't go on the formal record. If the insurer indicates they cannot consider the case, we pivot to another panel insurer or revisit timing. There is no need to put a "decline" entry against your application history.
A broker experienced with complex medical histories can identify panel insurers with documented appetite for post-cancer applications and pre-assess before formal submission.
Get Your Free AssessmentTrauma insurance (also called critical illness insurance) pays a lump sum on diagnosis of specified conditions. Cancer is a primary condition covered by trauma insurance, so a cancer history goes to the heart of what a trauma policy is being asked to insure. That is why trauma is underwritten on its own terms rather than following the life cover decision.
What insurers weigh on a trauma application after cancer:
If trauma cover is not workable, the other cover types are separate applications and are assessed separately:
When to apply:
When to wait:
Before applying, compile:
Documentation that strengthens your application:
Not every adviser handles complex medical applications regularly. A broker experienced with cancer histories can:
Why this matters:
Our approach:
We pre-assess across multiple panel insurers (AIA, Zurich, TAL, OnePath, ClearView, NEOS, Encompass, Acenda, Futura) before a formal application. The combined responses inform which insurer is approached formally and on what cover structure.
Critical warning: Disclose your complete cancer history. Non-disclosure or minimising your history can result in:
What to disclose:
Complete our quick quote form and one of our specialist advisers will review your situation. There's no obligation, and we'll give you honest feedback on your insurability.
Start Your QuoteUnderstanding the terminology:
For insurance purposes, what matters is:
Having had more than one cancer diagnosis means the underwriter is assessing more than one history:
If you've had cancer AND have family history:
If you developed cancer after taking out life insurance:
What an insurer looks at here is whether primary treatment (surgery, chemotherapy, radiotherapy) has finished and surveillance has begun. Insurers also distinguish ongoing maintenance therapy (for example, tamoxifen for hormone-receptor-positive breast cancer, or aromatase inhibitors) from primary treatment, and weigh the most recent surveillance result. Where each insurer draws those lines varies, and is best checked via pre-assessment.
There is no single answer. How long an insurer wants depends on the cancer type, the stage and grade at diagnosis, the treatment given, the surveillance record since, and that insurer's own underwriting manual. The honest answer is "it depends on cancer type, stage, treatment, and insurer". Pre-assessment with multiple panel insurers is the fastest way to find out for your specific situation.
A loading is generally set when the policy is issued and stays on that policy; check the relevant PDS for whether and how your insurer will review one. What can change is a fresh application, because that one is assessed on your health and your remission record as at that later date rather than as at inception. Reapplying periodically is therefore a reasonable strategy, and the pre-assessment costs nothing. If the new offer is materially better than your existing policy, you can take up the new cover. If it isn't, your existing policy continues unchanged. Never cancel the existing cover before the new cover is in force.
A decline at one panel insurer doesn't mean every panel insurer will decline. Each insurer applies its own underwriting manual and reinsurer arrangements. Remaining options typically include:
Yes. The Insurance Contracts Act 1984 (Cth) imposes a duty to take reasonable care not to make a misrepresentation when applying for cover. You should disclose every cancer diagnosis. This includes decades ago, non-recurrent diagnoses, and lesions classified at the time as "minor". A long, clean post-cancer history is actually a positive factor at underwriting. Concealing it is what creates problems if a claim is later assessed.
Income protection is underwritten on your capacity to work rather than on mortality, so a cancer history is assessed on a different question again. An IP offer can be shaped in several ways: a cancer-related exclusion, so that claims arising from a recurrence or new primary cancer do not pay while unrelated claims still can; a loading on the premium; or an adjusted benefit period or waiting period. Which of those applies, if any, is decided by the underwriter on the file. Pre-assessment is the fastest way to gauge.
Yes. TPD (Total and Permanent Disability) cover assesses functional ability rather than mortality, so the underwriter is answering a different question from the one life cover asks. Trauma cover is different again, because cancer is a primary insured event under most trauma definitions. The same cancer history is therefore assessed separately for each cover type, and the answer on one says little about the answer on another.
Possibly. After a cancer history, the insurer's medical evidence team may request:
These are normal parts of post-cancer underwriting and aren't a sign of bad news on their own.
In a qualitative sense, yes. Appetite varies. We don't publish per-insurer cancer underwriting tables for two reasons. First, insurers don't publish them. Second, appetite shifts as underwriting manuals are updated. The reliable answer comes from running a pre-assessment across multiple panel insurers. The pattern that emerges informs which insurer is the most likely fit for a formal application.
No, it doesn't generally affect a separate retail application. Group cover and retail cover are independent products. Group cover typically does not require individual underwriting. Holding both is common where the group cover sum insured isn't enough and a retail policy fills the gap.
A broker who regularly handles pre-existing condition applications, working across multiple insurers rather than one. The reasons are mechanical, not promotional. Insurer appetite for a given cancer history genuinely differs and shifts over time, so the job is matching your specific history (type, staging, time since treatment) to the insurer currently most likely to offer terms. Informal pre-assessment lets that matching happen before a formal application creates a decline on your record, which future applications would have to disclose. And when the realistic outcome is a loading or an exclusion rather than standard rates, an experienced broker will say so up front and explain what the offer means, instead of letting underwriting surprise you months in. If you would rather research first, the sections above set out how the assessment works; when you are ready to test the market, that testing is exactly what a panel comparison is for.
A cancer history changes how insurers approach an application. It doesn't, by itself, close the door on retail life insurance for most survivors.
What matters most:
Common considerations when planning an application:
Insure Me For Life works with all 9 Australian retail panel insurers and has experience with complex medical histories, including cancer. The broker's role is to:
We don't promise outcomes, and we don't claim relationships with insurers produce favourable underwriting. The underwriter decides. The broker's job is to make sure the decision is made on a properly prepared file at the most appropriate insurer.
General Advice Only
Insure Me For Life is Authorised Representative Number 1244847 of Consilium Advice Australia Pty Ltd, Australian Financial Services Licence 246623.